Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
214 articles
20 of 22
Sanofi CEO calls Onduo “e-commerce”. Express Scripts DHF.
12.13.19
6
min. Read
Sanofi’s in-house DTx. 1,162 clinical trials used digital tools in 2018.
12.06.19
5
min. Read
Proteus headcount dip. Smart pill standards.
11.22.19
6
min. Read
Google-Ascension recap. Deals, clearances, studies.
11.15.19
5
min. Read
FDA sleeps on AI/ML guidance. Google buys Fitbit for $2.1B
11.01.19
8
min. Read
Scoop: Stealthy OSA acquisition. Fake DTx unicorn?
10.25.19
5
min. Read
Pear-Sandoz’s conscious uncoupling. W. Virgina wants DTx.
10.18.19
7
min. Read
Roche-Genentech to develop in-house digital therapeutic. UHC. Livongo.
10.11.19
6
min. Read
Building digital therapeutics studies for the FDA vs. payers
10.04.19
15
min. Read
Senate bill mentions DTx. Pear lobbying. FDA vs payers.
10.04.19
6
min. Read
1 of 22